Low-Dose Apalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Case Report.
In: Cureus, Jg. 16 (2024-02-14), Heft 2, S. e54197
Online
report
Zugriff:
The effect of low-dose apalutamide in nonmetastatic castration-resistant prostate cancer is unknown. We report the observation of therapy being administered at 25% of the recommended dose in an 80-year-old patient. Despite treatment discontinuation during COVID lockdowns, he survived three years without evidence of metastasis. This case gently invites us to reflect on the possibility of low-dose apalutamide in the elderly.
Competing Interests: The authors have declared financial relationships, which are detailed in the next section.
(Copyright © 2024, Nguyen et al.)
Titel: |
Low-Dose Apalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Case Report.
|
---|---|
Autor/in / Beteiligte Person: | Nguyen, MD ; Natchagande, G ; Gorobets, O ; Vinh-Hung, V |
Link: | |
Zeitschrift: | Cureus, Jg. 16 (2024-02-14), Heft 2, S. e54197 |
Veröffentlichung: | Palo Alto, CA : Cureus, Inc., 2024 |
Medientyp: | report |
ISSN: | 2168-8184 (print) |
DOI: | 10.7759/cureus.54197 |
Sonstiges: |
|